Skip to main content
Click Here For COVID-19 Studies
Home
Clinical Trials Office Register as a Researcher Log In
318 Studies Now Enrolling
 Menu
Home How It Works Resources Join RecruitMe

Search

Reset

Status

  • Currently Recruiting (39)
  • Closed (163)

Medical Condition

  • Show all (1943)
  • Addiction (18)
  • Allergy, Asthma, & Immunology (13)
  • All of Us Research Program - NIH (1)
  • Autoimmune Disorders (28)
  • Blood Disorders (39)
  • Bone & Muscle (10)
  • Cancer (745)
    • Bladder Cancer (14)
    • Brain Cancer (25)
    • Breast Cancer (74)
    • Gastrointestinal (16)
    • Gynecologic Cancer (30)
    • Head and Neck Cancer (4)
    • Kidney Cancer (8)
    • Leukemia (77)
    • Liver Cancer (11)
    • Lung Cancer (65)
    • Lymphoma (45)
    • Multiple Myeloma (31)
    • Pancreatic Cancer (22)
    • Prostate Cancer (36)
    • (-) Sarcoma (25)
    • Skin Cancer (30)
    • Solid Tumors (42)
    • Thyroid Cancer (1)
    • Uveal Melanoma (7)
  • Child Development (4)
  • COVID-19 (Coronavirus) (36)
  • Critical Illness (1)
  • Diabetes (21)
  • Ear, Nose and Throat (11)
  • Endocrine & Metabolic Disease (12)
  • Eye (7)
  • Gastrointestinal and Digestive Diseases (25)
  • Hair and Skin Disorders (3)
  • Headaches (5)
  • Healthy Volunteers (185)
  • Heart Disease (128)
  • Infectious Disease (49)
  • Insomnia (2)
  • Kidney Disease (12)
  • Liver Disease (53)
  • Lung Disease (31)
  • Meniere's Disease (1)
  • (-) Neurological Disorders (177)
    • Alzheimer's Disease (39)
    • Brain Tumors (60)
    • Cerebral Palsy (2)
    • Dementia (8)
    • Huntington's Disease (3)
    • Multiple Sclerosis (8)
    • Neuromuscular (10)
    • Neuropathy (12)
    • Parkinson's Disease (3)
  • Nutrition (6)
  • Obesity (9)
  • Obstetrics & Gynecology (53)
  • Pain Management (1)
  • Pediatrics (102)
  • Psychiatric Disorders (67)
  • Rehabilitation (8)
  • Stroke (6)
  • Surgery (7)
  • Transplant (53)
  • Urology (4)
  • Vascular Conditions (10)
Displaying 201 - 202 of 202

Tolerability, Safety, and Activity of study drug SRX246 in Irritable Subjects With Huntington's Disease

Condition: Neurological Disorders / Huntington's Disease
Investigator: Karen Marder, MD, MPH
Status: Closed
The purpose of this research study is to find out whether a new investigational drug called SRX246, which might be useful to Huntington's Disease (HD) patients who sometimes feel irritable, angry, or even aggressive, is well tolerated and safe when it is given two times a day by mouth at doses as high as 160 mg. As part of this study, we will use a…
Read More

REGAL- Recurrent Glioblastoma Treated with Selinexor and Temozolomide

Condition: Neurological Disorders / Brain Tumors
Investigator: Andrew Lassman, MD
Status: Closed
The purpose of the research study is to see if selinexor has any effects against your cancer and toevaluate the side-effects of selinexor or selinexor in combination with temozolomide (TMZ ). One specific way cancer cells continue to grow is by getting rid of certain proteins called tumor suppressor proteins that would normally cause cancer cells to die.…
Read More

Pagination

  • Previous page ‹‹
  • Page 2
This website uses cookies as well as similar tools and technologies to understand visitors’ experiences. By continuing to use this website, you consent to Columbia University’s usage of cookies and similar technologies, in accordance with the Columbia University Website Cookie Notice.
I AGREE
COMPLIANCE
Compliance Hotline Compliance Program
RESOURCES
Terms of Use Privacy Policy ©2026 Columbia University
SCHOOLS
Vagelos College of Physicians and Surgeons Mailman School of Public Health School of Nursing College of Dental Medicine Graduate School of Arts and Science